RxDoctor Payments Data

Tram Vo

Family · Cypress, TXNPI 1073214672

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations.

$3,065in general payments, 2019–2025

Across 141 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$696
  • AstraZeneca$546
  • Bayer$376
  • Amgen$280
  • Radius Health, Inc.$151
  • Idorsia Pharmaceuticals US Inc$136
  • plus $879 from 13 others

What the payments were for

  • Food & beverage$3,065100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,065 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Cypress

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →